OxyContin maker Purdue Pharma LP is struggling with slumping sales, a shrinking workforce and restructuring challenges as it battles lawsuits related to the opioid crisis, according to people familiar with the company. Purdue’s revenue is expected to drop below $1 billion this year for the first time in more than a decade, as employees leave and a potential bankruptcy filing looms, people familiar with the matter say. Controlled by members of the billionaire Sackler family, Purdue has also been reviewing the corporate structure...

Source: Wall Street Journal June 30, 2019 09:32 UTC